新生儿早发型败血症计算器对培养确诊早发型败血症病例的分层:个体患者数据荟萃分析
234例EOS病例中,初始评估时40.6%被建议考虑经验性抗生素、15.4%加强生命体征监测、44.0%常规护理;至12小时龄分别变为61.1%、11.1%和27.8%。结论认为计算器可将相当比例EOS病例分至加强监测或常规护理,但所有新生儿仍需临床警惕。
要点
- EOS计算器初始评估将40.6%的培养确诊EOS病例分至考虑经验性抗生素。
- 至12小时龄,61.1%的EOS病例被分至考虑经验性抗生素。
- 初始评估44.0%的EOS病例被分至常规护理,12小时龄降至27.8%。
核心结论
- EOS计算器应用可将相当比例培养确诊EOS病例分至加强生命体征监测或常规护理。
- 对所有新生儿临床警惕仍然必不可少。
研究设计与样本
- 系统综述与个体患者数据荟萃分析,扩展PROSPERO记录CRD42018116188。
- 检索Cochrane、PubMed/MEDLINE、EMBASE、Web of Science、Google Scholar及主要会议论文集,时间2011年至2020年5月1日。
- 纳入独立于EOS计算器开发、包含代表性出生队列且应用EOS计算器的培养确诊EOS原始数据研究。
- 证据质量采用Newcastle-Ottawa量表、CHARMS和GRADE工具评估。
主要发现
- 234例EOS病例中,初始评估时95例(40.6%;95%CI,34.2%-47.2%)被分至(强烈考虑)经验性抗生素给药。
- 初始评估时36例(15.4%;95%CI,11.0%-20.7%)被分至加强生命体征监测。
- 初始评估时103例(44.0%;95%CI,37.6%-50.6%)被分至常规护理。
- 至12小时龄,143例(61.1%;95%CI,54.5%-67.4%)被分至(强烈考虑)经验性抗生素给药。
- 至12小时龄,26例(11.1%;95%CI,7.4%-15.9%)被分至加强生命体征监测,65例(27.8%;95%CI,22.1%-34.0%)被分至常规护理。
关键数值与推荐
- 初始评估时EOS计算器将40.6%(95%CI,34.2%-47.2%)的EOS病例分至(强烈考虑)经验性抗生素给药。
- 初始评估时EOS计算器将15.4%(95%CI,11.0%-20.7%)的EOS病例分至加强生命体征监测。
- 初始评估时EOS计算器将44.0%(95%CI,37.6%-50.6%)的EOS病例分至常规护理。
- 12小时龄时EOS计算器将61.1%(95%CI,54.5%-67.4%)的EOS病例分至(强烈考虑)经验性抗生素给药。
- 12小时龄时EOS计算器将11.1%(95%CI,7.4%-15.9%)的EOS病例分至加强生命体征监测,27.8%(95%CI,22.1%-34.0%)分至常规护理。
临床怎么用
- 临床可将EOS计算器用于初始和12小时龄风险评估,以分层决定经验性抗生素、加强监测或常规护理。
- 即使计算器分至常规护理,对所有新生儿仍需保持临床警惕。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To provide a comprehensive assessment of case stratification by the Neonatal Early-Onset Sepsis (EOS) Calculator, a novel tool for reducing unnecessary antibiotic treatment. STUDY DESIGN: A systematic review with individual patient data meta-analysis was conducted, extending PROSPERO record CRD42018116188. Cochrane, PubMed/MEDLINE, EMBASE, Web of Science, Google Scholar, and major conference proceedings were searched from 2011 through May 1, 2020. Original data studies including culture-proven EOS case(s) with EOS Calculator application, independent from EOS Calculator development, and including representative birth cohorts were included. Relevant (individual patient) data were extracted from full-text and data queries. The main outcomes were the proportions of EOS cases assigned to risk categories by the EOS Calculator at initial assessment and within 12 hours. Evidence quality was assessed using Newcastle-Ottawa scale, Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies, and GRADE tools. RESULTS: Among 543 unique search results, 18 were included, totaling more than 459 000 newborns. Among 234 EOS cases, EOS Calculator application resulted in initial assignments to (strong consideration of) empiric antibiotic administration for 95 (40.6%; 95% CI, 34.2%-47.2%), more frequent vital signs for 36 (15.4%; 95% CI, 11.0%-20.7%), and routine care for 103 (44.0%; 95% CI, 37.6%-50.6%). By 12 hours of age, these proportions changed to 143 (61.1%; 95% CI, 54.5%-67.4%), 26 (11.1%; 95% CI, 7.4%-15.9%), and 65 (27.8%; 95% CI, 22.1%-34.0%) of 234 EOS cases, respectively. CONCLUSIONS: EOS Calculator application assigns frequent vital signs or routine care to a substantial proportion of EOS cases. Clinical vigilance remains essential for all newborns.
引用
- Achten NB, Plötz FB, Klingenberg C, et al. Stratification of Culture-Proven Early-Onset Sepsis Cases by the Neonatal Early-Onset Sepsis Calculator: An Individual Patient Data Meta-Analysis. J Pediatr. 2021. PMID: 33545190. doi:10.1016/j.jpeds.2021.01.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。